Drug consumption rooms, opioid substitution treatment, overdose prevention, outreach work, etc.

Communicable disease prevention: Hepatitis B and C, HIV/AIDS, COVID-19, etc

Resources on specific drug categories, e.g. stimulants, opioids, new drugs, alcohol, nicotine, etc.

Drug policy, policy analysis, civil society involvment, criminalization, stigma

PWUD, PWID, WWUD, youth, aging, indigenous, incarcerated, etc.

Social work, social integration, general public health issues.

Over the last decade, so-called New Psychoactive Substances (NPS) appeared on the global markets. A sharp increase in the availability of ‘new’ illicit substances, such as new Synthetic Opioids (SO) is observed: substances with analgesic effects that are similar to those of heroin and morphine, but that are much stronger, more potent and associated with a higher risk of overdose.